Skip to content

Case control study for studying drug rash and find clinical and investigation markers predicting the severe form ( involvement of other vital organs)

TO STUDY THE EPIDEMIOLOGICAL PATTERN OF DRESS SYNDROME IN A TERTIARY CARE SETTING AND TO IDENTIFY THE CLINICAL, BIOCHEMICAL AND SEROLOGICAL MARKERS PREDICTING DRESS SYNDROME : A PROSPECTIVE CASE CONTROL STUDY

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/03/023918
Enrollment
50
Registered
2020-03-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L270- Generalized skin eruption due to drugs and medicaments taken internally

Interventions

None listed

Sponsors

PGIMER chandigarh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: INCLUSION CRITERIA FOR CASES: 1. Patients diagnosed as possible, probable and definitive DRESS syndrome (according to RegiSCAR criterion) 2. Age > 12 years. INCLUSION CRITERIA FOR CONTROLS: 1. Patients having drug induced maculopapular drug reaction and diagnosed as â??No DRESSâ?? according to RegiSCAR criterion. 2. Age > 12 years

Exclusion criteria

Exclusion criteria: EXCLUSION CRITERIA FOR CASES: 1. SCAR other than DRESS including erythema multiforme, Steven Johnson syndrome, toxic epidermal necrolysis, acute generalized exenthematous pustulosis, drug induced vasculitis. 2. Age

Design outcomes

Primary

MeasureTime frame
incidence of maculopapular drug rash epidemiology of drug involved systemic involvement ( as mentioned in RegiSCAR criterion) Tarc levelTimepoint: baseline 3-4 weeks 6-8 weeks 12 weeks

Secondary

MeasureTime frame
Time taken for resolution of rash. development of hypothyroidism.Timepoint: 3-4 weeks 6-8 weeks 12 weeks

Countries

India

Contacts

Public ContactDr M Sendhil Kumaran

POST GRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH

rajat.trn@gmail.com9001212304

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026